Skip to main content
ViroGates A/S logo

ViroGates A/S — Investor Relations & Filings

Ticker · VIRO ISIN · DK0061030574 LEI · 5493007TX8XS56RMZD94 ST Manufacturing
Open in API
Filings indexed 162 across all filing types
Latest filing 2023-02-01 Board/Management Inform…
Country DK Denmark
Listing ST VIRO

About ViroGates A/S

https://www.virogates.com/

ViroGates A/S is an in-vitro diagnostics company that develops and markets blood tests to measure chronic inflammation. The company's core product line, suPARnostic®, is based on the suPAR (soluble urokinase Plasminogen Activator Receptor) biomarker. This biomarker measures the activation level of the immune system to predict patient outcomes, disease risk, and the severity of chronic inflammation. The primary applications for suPARnostic® products are in hospitals for patient triaging, in the longevity market for health assessment, and in clinical research. The technology aims to improve patient care, optimize resource allocation in healthcare settings, and advance inflammation-based diagnostics.

Recent filings

Filing Released Lang Actions
ViroGates appoints Josephine Baum Jørgensen as its new Chief Financial Officer
Board/Management Information Classification · 100% confidence The document is a formal company announcement regarding the appointment of a new Chief Financial Officer (Josephine Baum Jørgensen) at ViroGates. It details her background, responsibilities, and includes quotes from the CEO. This falls directly under the category of board or management changes.
2023-02-01 English
ViroGates announces adjusted financial guidance for 2022 and 2023
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding an adjustment to financial guidance for 2022 and 2023. It provides specific revenue and EBIT figures and explains the reasoning behind the changes. This type of disclosure, which provides key financial highlights and outlook updates outside of a full quarterly or annual report, is classified as an Earnings Release (ER).
2022-12-16 English
ViroGates announces adjusted financial guidance for 2022 and 2023
Earnings Release Classification · 98% confidence The document is a company announcement from ViroGates regarding an adjustment to their financial guidance for 2022 and 2023. It provides specific revenue and EBIT figures and explains the reasoning behind the changes. This type of communication, which provides updates on financial expectations outside of a formal quarterly or annual report, is classified as an Earnings Release (ER) as it serves to inform the market of key financial performance highlights and outlook adjustments. FY 2022
2022-12-16 English
ViroGates announces CFO Mark da Silva to step down during Q1 2023
Board/Management Information Classification · 100% confidence The document is a formal company announcement regarding the resignation of the Chief Financial Officer (CFO). It details the departure of Mark da Silva and the interim management plan. This falls directly under the category of board or management changes.
2022-12-06 English
ViroGates announces CFO Mark da Silva to step down during Q1 2023
Board/Management Information Classification · 100% confidence The document is a company announcement regarding the resignation of the Chief Financial Officer (CFO). It explicitly states that the CFO is stepping down and outlines the interim management plan. This falls directly under the category of changes in senior management.
2022-12-06 English
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19
Director's Dealing Classification · 100% confidence The document is a standard regulatory form used in the EU (specifically Denmark, indicated by 'FINANSTILSYNET') for reporting transactions by persons discharging managerial responsibilities (PDMRs). It details the purchase of shares by the Chairman of the Board (Patrik Dahlen) of ViroGates A/S. This falls under the category of Director's Dealing.
2022-11-17 Danish

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.